tiprankstipranks
Cann Global Limited (DE:54A)
BERLIN:54A
Germany Market

Cann Global Limited (54A) Stock Price & Analysis

0 Followers

54A Stock Chart & Stats

Currently, no data available
Please return soon. This page is being updated.

Financials

Annual

54A FAQ

What was Cann Global Limited’s price range in the past 12 months?
Currently, no data Available
What is Cann Global Limited’s market cap?
Currently, no data Available
When is Cann Global Limited’s upcoming earnings report date?
Cann Global Limited’s upcoming earnings report date is Aug 28, 2024 which is in 121 days.
    How were Cann Global Limited’s earnings last quarter?
    Currently, no data Available
    Is Cann Global Limited overvalued?
    According to Wall Street analysts Cann Global Limited’s price is currently same. Get more investment ideas with TipRanks Premium
      Does Cann Global Limited pay dividends?
      Cann Global Limited does not currently pay dividends.
      What is Cann Global Limited’s EPS estimate?
      Cann Global Limited’s EPS estimate for its next earnings report is not yet available.
      How many shares outstanding does Cann Global Limited have?
      Currently, no data Available
      What happened to Cann Global Limited’s price movement after its last earnings report?
      Currently, no data Available
      Which hedge fund is a major shareholder of Cann Global Limited?
      Currently, no hedge funds are holding shares in DE:54A
      ---

      Cann Global Limited Stock Smart Score

      Company Description

      Cann Global Limited

      Cann Global Ltd is an Australian firm is engaged in the growing, cultivation and research and development of medical cannabis products. The company product portfolio consists of Seed, Oil, Bi-Products, Protein, Flour, Capsules and others. The business has three reportable segments: Hemp and medical cannabis products, Mining exploration and evaluation and corporate out of which the Hemp and Medicinal Cannabis Products segment act as a revenue driver for the firm. The firm generates substantial revenue within Australia and exports to the rest of the world.
      ---
      Similar Stocks
      Company
      Price & Change
      Follow
      Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.
      Parnell Pharmaceuticals
      Popular Stocks
      ---
      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis